Single institution experience with neoadjuvant chemotherapy in stage IB2 cervical cancer

被引：0
|
作者：
Limon, R. [1 ]
Ruiz, R. [1 ]
Serrano, M. [1 ]
Lopez, A. [2 ]
Alvarez, M. [2 ]
Marrufo, C. [2 ]
Luis, M. [1 ]
Valdiviezo, N. [1 ]
机构：
[1] INEN, Oncol, Lima, Peru
[2] INEN, Gynecol, Lima, Peru
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31492-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2725
引用
收藏
页码：S539 / S539
页数：1
相关论文
共 50 条
  • [1] Single institution experience with neoadjuvant chemotherapy in stage IB2 cervical cancer in Peru.
    Mas Lopez, Luis Alberto
    Lopez, A.
    Alvarez, M.
    Limon, R.
    Marrufo, C.
    Ruiz, R.
    Serrano, F.
    Pacheco, C.
    Valdiviezo, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy
    Jung-Yun Lee
    Yun Hwan Kim
    Min-Jeong Kim
    Kidong Kim
    Hyun Hoon Chung
    Noh-Hyun Park
    Yong-Sang Song
    Soon-Beom Kang
    [J]. Archives of Gynecology and Obstetrics, 2011, 284 : 477 - 482
  • [3] Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy
    Lee, Jung-Yun
    Kim, Yun Hwan
    Kim, Min-Jeong
    Kim, Kidong
    Chung, Hyun Hoon
    Park, Noh-Hyun
    Song, Yong-Sang
    Kang, Soon-Beom
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (02) : 477 - 482
  • [4] The Factors Which is Predict the Response to Neoadjuvant Chemotherapy in Stage IB2 Cervical Cancer
    Ozgul, Nejat
    Turan, Taner
    Kucukelci, Iltac
    Tulunay, Gokhan
    Boran, Nurettin
    Ozer, Suha
    Kog, Iskender
    Kose, Mehmet Faruk
    [J]. JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2008, 9 (03) : 152 - 157
  • [5] Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy
    Xu, X. F.
    Li, Q.
    Dai, A. Y.
    Zhou, H. J.
    Ling, J. X.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (03) : 489 - 491
  • [6] Are the outcomes of neoadjuvant chemotherapy for stage IB2 cervical cancer similar in pregnant and nonpregnant patient?
    Morice, Philippe
    Uzan, Catherine
    Leary, Alexandra
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 257 - +
  • [7] Experience in stage IB2 cervical cancer and review of treatment
    Turan, Taner
    Yildirim, Burcu Aykan
    Tulunay, Gokhan
    Boran, Nurettin
    Yildiz, Ferah
    Kose, Mehmet Faruk
    [J]. JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2010, 11 (01) : 27 - 37
  • [8] Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer
    Sanson, Claire
    Zaccarini, Francois
    Majer, Michael
    Pautier, Patricia
    Genestie, Catherine
    Chargari, Cyrus
    Gouy, Sebastien
    Morice, Philippe
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (05) : 680 - 685
  • [9] Reply to: Are the outcomes of neoadjuvant chemotherapy for stage Ib2 cervical cancer similar in pregnant and nonpregnant patients?
    Fruscio, Robert
    Mangioni, Costantino
    Milani, Rodolfo
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 258 - 259
  • [10] Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study
    Yan, Wenxing
    Qiu, Shuang
    Si, Lihui
    Ding, Yaming
    Zhang, Qi
    Liu, Linlin
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1894 - 1902
12345